News
Filter
-
MRC Technology collaborates with NYU School of Medicine to develop biologics for inflammatory bone disease
-
MRC Technology appoints Finance Director
-
MRC Technology Negotiates Licence Deal with Quantifoil Micro Tools GmbH for Ultrastable Gold Support (UltrAuFoil) Technology
-
Immunotherapy drugs could herald new era in cancer treatment
-
MRC Technology and Cyclofluidic announce the successful completion of a hit optimisation project
-
First Treatment Approved under EAMS Developed Using MRC Technology Antibody Humanization Expertise
-
Immunotherapy: boosting your body to fight cancer
-
Respiratory ‘Call for Targets’ launched
-
MRC Technology appoints General Counsel and Company Secretary
-
Kick-starting stalled drugs for brain diseases
-
MRC Technology to manage Diabetes UK’s IP
-
Key US Patents Granted for GPCR-Focused Drug Discovery Platform Arising From Pioneering Research and Translational Expertise at MRC and MRC Technology
